Pacific Biosciences of California PACB Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $12.47M-15.5% | $14.76M-8.1% | $16.05M-19.5% | $19.95M-6.4% | $21.32M-10.4% | ||
| -$128.58M+76.5% | -$546.38M-8.0% | -$506.01M+4.3% | -$528.73M+19.9% | -$660.12M-111% | ||
| -$119.15M+30.5% | -$171.43M+38.2% | -$277.32M+6.0% | -$294.95M+29.7% | -$419.27M+3.2% | ||
| -$133.28M+75.9% | -$553.86M+16.8% | -$665.69M+3.6% | -$690.89M+15.9% | -$821.89M-73.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Pacific Biosciences of California's revenue?
- Pacific Biosciences of California (PACB) generated $160.0M in revenue over the trailing twelve months, up 5.0% year over year.
- Is Pacific Biosciences of California profitable?
- Pacific Biosciences of California is not currently profitable: it reported a net loss of $128.6M over the trailing twelve months, a -80.3% net margin.
- What are Pacific Biosciences of California's profit margins?
- Gross margin is 37.5% and operating margin is -83.3%, with a -80.3% net margin.
- What is Pacific Biosciences of California's earnings per share?
- Pacific Biosciences of California's diluted EPS over the trailing twelve months is $-0.43.
- Where does Pacific Biosciences of California's income statement data come from?
- Every line is extracted from Pacific Biosciences of California's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
